Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6503577 | 0.88 | ALDH1A1 (0.34) | L3MBTL1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6504082 | 0.86 | MEN1 (0.39) | MEN1KMT2AALDH1A1POLB | |
| SCHEMBL6501686 | 0.85 | NPSR1 (0.39) | MEN1KMT2AALDH1A1POLBMAPT | |
| SCHEMBL6503540 | 0.85 | MEN1 (0.39) | L3MBTL1MEN1KMT2APOLBMAPT | |
| SCHEMBL6510626 | 0.84 | TDP1 (0.34) | MEN1KMT2AALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL6429803 | 0.84 | RAB9A (0.38) | ALDH1A1POLBMAPTSMN1; SMN2GAA | |
| SCHEMBL6501528 | 0.83 | L3MBTL1 (0.36) | L3MBTL1MAPTNPSR1ELANEKDM4E | |
| SCHEMBL6506231 | 0.83 | KMT2A (0.37) | KMT2AALDH1A1POLBMAPTGAA | |
| SCHEMBL6505095 | 0.82 | KDM4E (0.32) | L3MBTL1ALDH1A1MAPTKDM4E | |
| SCHEMBL6499622 | 0.81 | HPGD (0.35) | L3MBTL1MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050239853-A1 | New compounds | BIOVITRUM AB (SE) | 2005-10-27 | — | — | US | claimed |
| US-20050239853-A1 | New compounds | BIOVITRUM AB (SE) | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239853-A1 | New compounds | HSD11B1, CYP11B1, HSD3B1 | L3MBTL1 4470/4885MEN1 979/4885KMT2A 3213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.